Jake Gottlieb Takes New Fund Altium Public

As technology keeps advancing rapidly, so does the world of medicine. Investors like Jake Gottlieb make it a point to stay informed about the latest developments to give the best investment opportunities for his clients. With decades of experience in the healthcare sector, he is looking forward to getting his new firm Altium off the ground and running. Even though they just made their first public offering earlier this year, they have already started building up an impressive team.

For the first time in decades, Jacob Gottlieb will be working with Stuart Weisbrod. Weisbrod is a co-founder of the Merlin BioMed Group in which Jake Gottlieb worked with during the biotech revolution of the early 2000s. With their experience and investment know-how combined, people are expecting some big things out of Altium. The new firm Altium is a hedge fund that invests into companies within the healthcare sector that have gone public.

Altium is the newest hedge fund by Jake Gottlieb who is still in the process of shutting the doors of his former company. While some may have moved on to a different industry after being rocked by a scandal like Jake Gottlieb’s Visium experiences, he refuses to let the bad actions of others destroy his career. He remains adament that he had no knowledge and nothing to do with the illegal trading that had been happening behind the scenes involving a small group of Visium executives.

Altium has already made a significant investment into a biotech company that Jake Gottlieb thinks may have a considerable amount of potential to change the lives of millions of patients living with diabetes. They recently purchased 5.61% of the shares of Oramed, a company founded in 2006. Currently, injecting insulin through a syringe or pump is essentially the only way to take the medication. Researchers have been trying to make an oral version of the medication for decades but have not had much success in keeping the protein viable long enough to be absorbed. With Oramed’s technology that is in the process of FDA approval, patients may not have to deal with the discomfort of injections anymore.

Find out more about Jake Gottlieb Altium: https://ideamensch.com/jacob-gottlieb/

Leave a Reply

Your email address will not be published / Required fields are marked *